Related Experiment Video
Updated: Apr 5, 2026

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
Published on: June 25, 2019
Pathophysiology of pyoderma gangrenosum (PG): an updated review
Sara F Braswell1, Tassia C Kostopoulos1, Alex G Ortega-Loayza1
1Department of Dermatology, Virginia Commonwealth University, Richmond, Virginia.
Abstract:
Pyoderma gangrenosum is a challenging skin condition to identify and treat because of its multifactorial pathogenesis. It is a rare cutaneous manifestation diagnosed clinically by exclusion of infection, neoplasia, thrombophilia, and other inflammatory conditions. Pathogenetic and treatment studies are scarce. Abnormalities in the function of inflammatory cytokines, the immune system, and neutrophils combined with specific genetic mutations predispose patients to develop this complex disease process. Early recognition of patients at risk for pyoderma gangrenosum, the necessity to improve its early diagnosis, and the future outlook of targeted and personalized therapies relies on the improved comprehension of the complex pathogenesis of pyoderma gangrenosum.
Insights
Pyoderma gangrenosum is a rare skin condition with complex causes. Understanding its pathogenesis is key for early diagnosis and developing targeted treatments.
Area of Science:
- Dermatology
- Immunology
- Genetics
Background:
- Pyoderma gangrenosum (PG) is a challenging ulcerative skin disease.
- Diagnosis is clinical and often requires excluding other conditions like infection or neoplasia.
- The multifactorial pathogenesis involves immune dysregulation and genetic factors.
Purpose of the Study:
- To highlight the complexity of pyoderma gangrenosum pathogenesis.
- To emphasize the need for improved diagnostic strategies.
- To discuss the future of personalized therapies for PG.
Main Methods:
- This study is a review of current understanding of pyoderma gangrenosum.
- It synthesizes information on pathogenetic factors and treatment challenges.
- No new experimental data was generated.
Main Results:
- Pyoderma gangrenosum pathogenesis is complex, involving cytokines, immune cells, and genetics.
- Current diagnostic methods rely on exclusion, leading to delays.
- Treatment options are limited, and research is scarce.
Conclusions:
- A deeper understanding of pyoderma gangrenosum's complex pathogenesis is crucial.
- Early recognition and improved diagnosis are necessary.
- Future research should focus on targeted and personalized therapies.
Related Concept Videos
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Peripheral Artery Disease I: Introduction
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Staphylococcal Skin Infections
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
